Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Ariad sells off a share of Iclusig for a shot at $200M in R&D cash
Ariad sells off a share of Iclusig for a shot at $200M in R&D cash
Ariad sells off a share of Iclusig for a shot at $200M in R&D cash
Submitted by
admin
on July 29, 2015 - 10:04pm
Source:
Fierce Biotech
News Tags:
Ariad Pharmaceuticals
R&D
Iclusig
acute lymphoblastic leukemia
PDL Biopharma
Headline:
Ariad sells off a share of Iclusig for a shot at $200M in R&D cash
Do Not Allow Advertisers to Use My Personal information
